The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings-Reference-Cited by-同舟云学术

The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings

Published:2013-04-10 Issue:10 Volume:38 Page:1921-1928
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Musselman Dominique,Royster Erica B,Wang Ming,Long Qi,Trimble Lisa M,Mann Tara K,Graciaa Daniel S,McNutt Marcia D,Auyeung N S Freda,Oliver Lindsay,Lawson David H,Miller Andrew H

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp201385.pdf

Reference44 articles.

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders 4th edn. American Psychiatric Association: Washington, DC, USA.

2. Anisman H, Merali Z (1999). Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 461: 199–233.

3. Bindon C, Czerniecki M, Ruell P, Edwards A, McCarthy WH, Harris R et al (1983). Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects. Br J Cancer 47: 123–133.

4. Butler LD, Mohler KM, Layman NK, Cain RL, Riedl PE, Puckett LD et al (1989). Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic intervention. Immunopharmacol Immunotoxicol 11: 445–487.

5. Capuron L, Ravaud A, Dantzer R (2000). Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 18: 2143–2151.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressants for the treatment of depression in people with cancer;Cochrane Database of Systematic Reviews;2023-03-31

2. A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer;Brain, Behavior, & Immunity - Health;2022-05

3. Metabolomic and inflammatory signatures of symptom dimensions in major depression;Brain, Behavior, and Immunity;2022-05

4. Medikamentös-induzierte psychiatrische Nebenwirkungen;PSYCH up2date;2022-05

5. Assessing Depressive Symptoms in Patients With Cancer Treated With Interleukin-2;Cancer Nursing;2022-01-27